This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT05386550
Brief Title: Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

First Submitted : May 17, 2022
First Submitted that Met QC Criteria : May 17, 2022
First Posted : May 23, 2022

Last Update Submitted that Met QC Criteria : March 5, 2024
Last Update Posted : March 6, 2024